For the quarter ending 2026-03-31, CIMP had $198,561K increase in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net income (loss) | -43,910 | 28,332 | 202,167 |
| (accretion) amortization of investment discounts/premiums, net | 9,171 | 13,588 | 11,083 |
| Accretion of deferred financing costs, debt issuance costs, and securitized debt discounts/premiums, net | 4,377 | 5,969 | 12,606 |
| Net unrealized (gains) losses on derivatives | 18,150 | 27,303 | -16,932 |
| Proceeds (payments) for derivative settlements | -111 | 0 | 0 |
| Margin (paid) received on derivatives | -36,901 | 8,916 | 61,027 |
| Net unrealized losses (gains) on financial instruments at fair value | - | - | 98,872 |
| Net unrealized (gains) losses on financial instruments at fair value | -37,536 | 81,733 | - |
| Net realized losses on sales of investments | -40,428 | -23,268 | 76 |
| Other investment losses | -910 | 1,252 | 4,481 |
| Net increase in provision for credit losses | 2,824 | 5,322 | 10,383 |
| Amortization of intangibles and depreciation expenses | - | 4,333 | 2,850 |
| Depreciation, amortization, and impairment expense | 9,649 | - | - |
| Gain on origination and sale of loans, net | -1,569 | 1,228 | - |
| (gain) loss on extinguishment of debt | -38,858 | 20 | 2,122 |
| Equity-based compensation expense | 2,726 | 1,685 | 8,009 |
| Non-cash imputed compensation related to business acquisition | 341 | 341 | 1,023 |
| Direct loan origination costs, net | 883,530 | 1,037,559 | - |
| Sales, settlements and proceeds from sale of loans held-for-sale | 1,070,654 | 671,589 | - |
| Fair value adjustment on mortgage loans held-for-sale | -8,284 | 7,798 | - |
| Decrease (increase) in accrued interest receivable | -2,328 | 2,541 | -9,154 |
| Decrease in other assets | 67,199 | -194,224 | 182,465 |
| Increase in accounts payable and other liabilities | 17,117 | -9,941 | 4,331 |
| Decrease in accrued interest payable | -6,197 | 2,717 | -3,436 |
| Net cash provided by operating activities | 243,318 | -152,772 | -96,107 |
| Purchases-Agency Mortgage Backed Securities | 1,299,085 | 909,674 | 3,316,400 |
| Sales-Agency Mortgage Backed Securities | 0 | 110,770 | 1,045,557 |
| Principal payments-Agency Mortgage Backed Securities | 110,043 | 91,163 | 101,434 |
| Purchases-Non Agency Residential Mortgage Backed Securities | 0 | 0 | 0 |
| Sales-Non Agency Residential Mortgage Backed Securities | 13,491 | 23,075 | 141,967 |
| Principal payments-Non Agency Residential Mortgage Backed Securities | 36,568 | 19,278 | 72,909 |
| Purchases-Loans Held For Investment | 1,845 | 1,610 | 439,773 |
| Sales-Loans Held For Investment | 1,197,074 | 154,934 | 0 |
| Principal payments-Loans Held For Investment | 299,481 | 358,061 | 1,112,512 |
| Payments to acquire businesses-Home Xpress Mortgage Corp | - | 183,034 | - |
| Payments to acquire businesses-Palisades Group | - | 0 | - |
| Payments on purchases of investment in msr financing receivables | - | 0 | 38,221 |
| Receipt of distributions on investment in msr financing receivables | - | - | 0 |
| Net cash provided by (used in) investing activities | 355,727 | -337,038 | -1,320,015 |
| Proceeds from secured financing agreements | 15,721,751 | 16,259,630 | 38,239,697 |
| Payments on secured financing agreements | 14,764,508 | 15,570,123 | 36,197,462 |
| Payments on repurchase of common stock | - | 0 | - |
| Proceeds on issuance of common stock | - | 0 | - |
| Proceeds from securitized debt borrowings, collateralized by loans held for investment | 0 | 0 | 1,011,244 |
| Payments on securitized debt borrowings, collateralized by loans held for investment | 1,304,275 | 352,977 | 1,190,353 |
| Payments on securitized debt borrowings, collateralized by non-agency rmbs | 1 | 1 | 16 |
| Net proceeds from issuance of unsecured debt | - | 0 | 115,494 |
| Common dividends paid | 32,354 | 31,897 | 90,805 |
| Preferred dividends paid | 21,097 | 21,831 | 64,200 |
| Net cash (used in) provided by financing activities | -400,484 | 282,801 | 1,823,599 |
| Net increase in cash, cash equivalents and restricted cash | 198,561 | -207,009 | 407,477 |
| Cash, cash equivalents and restricted cash at beginning of period | 284,465 | 491,475 | 83,998 |
| Cash, cash equivalents and restricted cash at end of period | 483,026 | 284,465 | 491,475 |
CHIMERA INVESTMENT CORP (CIMP)
CHIMERA INVESTMENT CORP (CIMP)